Skip to content

Quest Diagnostics DGX Enterprise value

Enterprise value at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$28.24B+10.2%
Natera, Inc. logo
Natera, Inc.NTRA
$27.5B+49.9%
Agilent Technologies logo
Agilent TechnologiesA
$34.39B+5.1%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$45B+30.0%
Danaher logo
DanaherDHR
$148.16B-8.7%
Guardant Health logo
Guardant HealthGH
$12.72B+121%

Other financials

Income statement

See full
Revenue$2.9B+9.2%
Gross profit$942.0M+9.2%
Operating income$399.0M+15.3%
Net income$252.0M+14.5%
EPS (diluted)$2.24+15.5%

Balance sheet

See full
Cash & equivalents$393.0M+109%
Total debt$6.4B-2.5%
Total equity$7.4B+6.3%
Total assets$16.7B+5.6%

Cash flow

See full
Operating cash flow$278.0M-11.5%
CapEx$114.0M-2.6%
Free cash flow$164.0M-16.8%

Valuation

See full
Market cap$21.89B+14.7%
P/E21.4×+0.1×
P/S1.9×+0.1×

Profitability

See full
Gross margin33.2%+0.4pp
Operating margin14.3%+0.6pp
Net margin9.1%+0.2pp

Returns & leverage

See full
Return on equity14.3%+0.9pp
Debt / equity0.9×-0.1×
Current ratio1.2×-0.3×

Where this comes from

Calculated from Quest Diagnostics’s reported figures.

The official record: Quest Diagnostics’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Quest Diagnostics's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Quest Diagnostics's enterprise value?
Quest Diagnostics (DGX) reported enterprise value of $27.54B in Q1 2026.
How has Quest Diagnostics's enterprise value changed year-over-year?
Quest Diagnostics's enterprise value increased by 9.5% year-over-year, from $25.16B to $27.54B.
What is the long-term trend for Quest Diagnostics's enterprise value?
Over 4 years (2021 to 2025), Quest Diagnostics's enterprise value has grown at a 4.8% compound annual growth rate (CAGR), from $85.98B to $103.86B.
What does enterprise value mean?
What it would cost to buy the entire business, debt included and cash netted out.
How do you interpret enterprise value?
The capital-structure-neutral valuation base — used in EV/EBITDA and EV/Sales to compare companies with different leverage on a like-for-like footing.
How does enterprise value compare across companies?
Comparable across non-financial companies via the EV multiples it feeds; not used for banks and insurers.